(Q28257093)

2

0 references

Zhichao Yin

3

0 references

Sen Feng

4

0 references

Liping Sun

5

0 references

Zhiyu Li

Future Medicinal Chemistry

6

0 references

language of work or name

English

0 references

publication date

2015

0 references

published in

1 reference

Tumor immune escape mediated by indoleamine 2,3-dioxygenase

PubMed

volume

7

0 references

issue

2

0 references

page(s)

185-201

0 references

cites work

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

In vitro modulation of cytochrome P450 reductase supported indoleamine 2,3-dioxygenase activity by allosteric effectors cytochrome b(5) and methylene blue

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

The first step of the dioxygenation reaction carried out by tryptophan dioxygenase and indoleamine 2,3-dioxygenase as revealed by quantum mechanical/molecular mechanical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Oxidation of L-tryptophan in biology: a comparison between tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Creating immune privilege: active local suppression that benefits friends, but protects foes.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Indoleamine 2,3-dioxygenase and tumor-induced tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Modulation of tryptophan catabolism by regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

1-Methyl-DL-tryptophan, beta-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

The missing link between indoleamine 2,3-dioxygenase mediated antibacterial and immunoregulatory effects

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Heme-Containing Oxygenases

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Genotyping and expression analysis of IDO2 in human pancreatic cancer: a novel, active target

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O2 incorporation by a heme-containing dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Rational design of indoleamine 2,3-dioxygenase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Indoleamine 2,3-dioxygenase inhibitors: a patent review (2008 - 2012).

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Prevention of allogeneic fetal rejection by tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Inhibition of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase by beta-carboline and indole derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Enzyme kinetic and spectroscopic studies of inhibitor and effector interactions with indoleamine 2,3-dioxygenase. 1. Norharman and 4-phenylimidazole binding to the enzyme as inhibitors and heme ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Indoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Synthesis of indoleamine 2,3-dioxygenase inhibitory analogues of the sponge alkaloid exiguamine A.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Structure-activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Virtual screening of chemical libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Synthesis and biological activity of 1-methyl-tryptophan-tirapazamine hybrids as hypoxia-targeting indoleamine 2,3-dioxygenase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Indoleamine 2,3-dioxygenase inhibitors from the Northeastern Pacific Marine Hydroid Garveia annulata.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Exiguamine A, an indoleamine-2,3-dioxygenase (IDO) inhibitor isolated from the marine sponge Neopetrosia exigua

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Biomimetic synthesis of the IDO inhibitors exiguamine A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Inhibitory substrate binding site of human indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Detection and quantification of Plectosphaerella cucumerina, a potential biological control agent of potato cyst nematodes, by using conventional PCR, real-time PCR, selective media, and baiting.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Synthesis and antitumor characterization of pyrazolic analogues of the marine pyrroloquinoline alkaloids: wakayin and tsitsikammamines

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Indoleamine 2,3-dioxygenase inhibitory activity of derivatives of marine alkaloid tsitsikammamine A.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

The selenazal drug ebselen potently inhibits indoleamine 2,3-dioxygenase by targeting enzyme cysteine residues

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Lignans from Carthamus tinctorius suppress tryptophan breakdown via indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Interaction of Carthamus tinctorius lignan arctigenin with the binding site of tryptophan-degrading enzyme indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151

Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.14.151